Skip to main content
Equibles
ENOV logo

ENOV · Enovis CORP · Metrics

Track ENOV — free

Use ENOV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENOV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.30 +0.49 (+2.33%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.20B
Shares
57.67M
Volume · Oct 22 36.08K Avg daily vol (3M) 1.49M

ENOV metrics

100 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.81
Market cap
$1.20B

Price action

20 metrics
Price change (1W)
+12.1%
Price change (30D)
+13.2%
Price change (3M)
-21.6%
Price change (6M)
-12.4%
Price change (YTD)
-21.9%
Price change (1Y)
-35.5%
Trailing year
Price change (5Y)
—
52-week high
$32.87
52-week low
$17.43
Change from 52-week high
-36.7%
Change from 52-week low
+19.4%
Annualized volatility
63.4%
Annualized volatility (3M)
66.0%
Beta
1.4
RSI (14D)
61.3
Price vs SMA 50
+1.0%
Price vs SMA 200
-10.6%
Avg volume (3M)
1.49M
Relative volume
0.8
Average dollar volume
$31.81M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
57.67M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 92.9%
EV / EBITDA
8.0×
reciprocal yield 12.5%
EV / EBIT
—
P / sales
0.5×
reciprocal yield 191.4%
P / book
0.8
reciprocal yield 123.1%
FCF yield
5.3%
TTM · current market cap
Buyback yield
—
P / FCF
18.9
reciprocal yield 5.3%
P / operating cash flow
4.4
reciprocal yield 22.5%
Earnings yield
-91.8%

Historical valuation

8 metrics
P / E historical average (3Y)
96.1×
reciprocal yield 1.0%
P / E historical average (5Y)
96.1×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
1.6×
reciprocal yield 60.7%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 60.0%
EV / EBIT historical average (3Y)
28.0×
reciprocal yield 3.6%
EV / EBIT historical average (5Y)
28.0×
reciprocal yield 3.6%
EV / EBITDA historical average (3Y)
21.0×
reciprocal yield 4.8%
EV / EBITDA historical average (5Y)
19.3×
reciprocal yield 5.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
61.1%
Operating margin
-45.1%
Trailing 12 months
Net margin
-48.0%
Gross profit (TTM)
$1.40B
Operating profit (TTM)
−$1.04B
Net income (TTM)
−$1.10B
Trailing 12 months
Diluted EPS (TTM)
$-19.30
FCF margin
2.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$40.07
Gross profit per diluted share (TTM)
$24.48
Operating profit per diluted share (TTM)
$-18.13
EBITDA per diluted share (TTM)
$5.38
Net income per diluted share (TTM)
$-19.27
Operating cash flow per diluted share (TTM)
$4.71
Free cash flow per diluted share (TTM)
$1.11
Capital expenditures per diluted share (TTM)
$3.60
R&D per diluted share (TTM)
$2.17
Stock compensation per diluted share (TTM)
$0.60
Book value per share
$26.05

Growth

11 metrics
Revenue growth YoY
+3.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.30B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+12.9%
Revenue CAGR (5Y)
+14.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-36.1%

Quality

14 metrics
Return on equity
-74.6%
Return on assets
-29.3%
Debt / equity
0.9
Current ratio
2.0
EBITDA (TTM)
$308.80M
Free cash flow (TTM)
$63.66M
Quick ratio
1.0
Interest coverage
-30.9
Net debt / EBITDA
4.1
Return on invested capital
—
Trailing 12 months
Net cash
−$1.27B
Latest balance sheet
Cash & equivalents
$12.56M
Total assets
$3.77B
Total debt
$1.28B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$270.10M
Capital expenditures (TTM)
$206.44M
R&D (TTM)
$124.32M
SG&A (TTM)
$1.08B
Stock compensation (TTM)
$34.56M
R&D / revenue
5.4%
Stock compensation / revenue
1.5%

Ownership (13F)

9 metrics
13F filers
256
13F filer change QoQ
0
Institutional ownership
126.1%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.8%
Holder tenure
11.0
Price vs estimated holder cost
-38.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
29.0%

Short interest

3 metrics
Short interest
18.3%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
$449,599
Insider-sentiment score
88 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1420800 CUSIP 194014502 13F (30d) 26 filings 26 filers Visit website Investor relations